0
Your cart

Your cart is empty

Books > Medicine > Other branches of medicine > Pharmacology

Buy Now

endoCANNABINOIDS - Actions at Non-CB1/CB2 Cannabinoid Receptors (Hardcover, 2013 ed.) Loot Price: R4,868
Discovery Miles 48 680
You Save: R640 (12%)
endoCANNABINOIDS - Actions at Non-CB1/CB2 Cannabinoid Receptors (Hardcover, 2013 ed.): Mary E. Abood, Roger G. Sorensen, Nephi...

endoCANNABINOIDS - Actions at Non-CB1/CB2 Cannabinoid Receptors (Hardcover, 2013 ed.)

Mary E. Abood, Roger G. Sorensen, Nephi Stella

Series: The Receptors, 24

 (sign in to rate)
List price R5,508 Loot Price R4,868 Discovery Miles 48 680 | Repayment Terms: R456 pm x 12* You Save R640 (12%)

Bookmark and Share

Expected to ship within 12 - 17 working days

This book is intended as a scientific resource for cannabinoid researchers carrying out animal and human experiments, and for those who are interested in learning about future directions in cannabinoid research. Additionally, this book may be of value to investigators currently working outside the field of cannabinoid research who have an interest in learning about these compounds and their atypical cannabinoid signalling. This book provides insight into the potential medical application of cannabinoids and their therapeutic development for the treatment of human disease.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: The Receptors, 24
Release date: October 2012
First published: 2013
Editors: Mary E. Abood • Roger G. Sorensen • Nephi Stella
Dimensions: 235 x 155 x 23mm (L x W x T)
Format: Hardcover
Pages: 288
Edition: 2013 ed.
ISBN-13: 978-1-4614-4668-2
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
Promotions
LSN: 1-4614-4668-6
Barcode: 9781461446682

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners